CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 16, Issue 3, Pages 220-230
Publisher
Springer Nature
Online
2015-06-16
DOI
10.1038/tpj.2015.42
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of CES1A2 A(−816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease
- (2014) Cheng Xie et al. Pharmacogenetics and Genomics
- CES1A −816C as a Genetic Marker to Predict Greater Platelet Clopidogrel Response in Patients with Percutaneous Coronary Intervention
- (2013) Jian-Jun Zou et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis
- (2013) Seyed Hamidreza Mahmoudpour et al. PHARMACOGENOMICS
- A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for moexipril, an angiotensin-converting enzyme inhibitor in human plasma
- (2012) Vijaya Kumari Karra et al. BIOMEDICAL CHROMATOGRAPHY
- Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans
- (2012) E K Tarkiainen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans
- (2012) Yuki Suzaki et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate
- (2012) E M Bruxel et al. PHARMACOGENOMICS JOURNAL
- Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study
- (2011) George Tsoukas et al. American Journal of Cardiovascular Drugs
- Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11
- (2010) M. Jason Hatfield et al. BIOCHEMICAL PHARMACOLOGY
- Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients
- (2010) Kimie Sai et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0
- (2010) Giulio Vistoli et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study
- (2010) Ettore Malacco et al. JOURNAL OF HYPERTENSION
- Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis
- (2010) Alastair JS Webb et al. LANCET
- Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity
- (2010) S Yamada et al. PHARMACOGENOMICS JOURNAL
- Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril
- (2009) Hao-Jie Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Antihypertensive Efficacy of Perindopril 5–10 mg/day in Primary Health Care
- (2009) Dan-Dominic Ionescu CLINICAL DRUG INVESTIGATION
- Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD
- (2009) Zsofia Nemoda et al. NEUROPHARMACOLOGY
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis
- (2008) Hao-Jie Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
- (2008) Dongfang Yang et al. BIOCHEMICAL PHARMACOLOGY
- Simultaneous Determination of Ramipril and Its Active Metabolite Ramiprilat in Human Plasma by LC–MS–MS
- (2008) Bo Yuan et al. CHROMATOGRAPHIA
- Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
- (2008) H.-J. Zhu et al. DRUG METABOLISM AND DISPOSITION
- Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
- (2008) Masakiyo Hosokawa MOLECULES
- Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes
- (2008) Tatsuki Fukami et al. Pharmacogenetics and Genomics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now